That matters because glucagon activation increases your baseline calorie burn and enhances fat breakdown through heat production, basically adding a metabolic accelerator that semaglutide and tirzepatide lack entirely
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
Monster Energy, the second-largest brand by mental market share, loses 3.5pp in the segment and narrows in occasion breadth
Stacking & comparisons Retatrutide is the most receptor-broad metabolic compound we stock
118 It has been shown to improve comorbidities like T2DM, dyslipidemia, sleep apnea, and hypertension and reduce cardiovascular risk
Units depend on concentration, not just dose: the same 2mg dose is 40 units at 5mg/mL but only 20 units at 10mg/mL